Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements

This document provides guidance on brand name assessment, inner and outer product labels, and risk management planning.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:33 (UTC)
Created April 17, 2026, 17:33 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-03-30 00:00:00
open_canada_keywords {"fr": ["COVID-19", "virus SARS-CoV-2", "vaccins COVID-19", "médicaments COVID-19", "exigences d'autorisation de mise sur le marché", "exigences d'étiquetage", "exigences post-commercialisation"], "en": ["COVID-19", "SARS-CoV-2 virus", "COVID-19 vaccines", "COVID-19 drugs", "market authorization requirements", "labelling requirements", "post-market requirements"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Exigences d’étiquetage et de post-commercialisation
update_frequency as_needed